IRIS

O'Day, S.j., Schadendorf, D., Weber, J., Lebbe, C., Maio, M., Pehamberger, H., et al. (2009). P7 Treatment with lpllimumab brings an advantage with reference to long-term survival: reflection rate after 24-months of patients with advanced melanoma from 3 phase II studies with 10mg/kg lpillimumab. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 7(9), 834-835.

P7 Treatment with lpllimumab brings an advantage with reference to long-term survival: reflection rate after 24-months of patients with advanced melanoma from 3 phase II studies with 10mg/kg lpillimumab

Maio M;
2009-01-01
2009
O'Day, S.j., Schadendorf, D., Weber, J., Lebbe, C., Maio, M., Pehamberger, H., et al. (2009). P7 Treatment with lpllimumab brings an advantage with reference to long-term survival: reflection rate after 24-months of patients with advanced melanoma from 3 phase II studies with 10mg/kg lpillimumab. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 7(9), 834-835.
1.5 Abstract in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1081109